REGENERON PHARMACEUTICALS, INC. insiders: buys and sells · REGN

Directors, officers and 10%+ shareholders must report every purchase and sale of their company's stock to the SEC within two business days. Transactions filed between 2026-10-14 and 2026-10-14. All filings on SEC EDGAR →

Bought: $0
Sold: $3,204,376
Buys: 0
Sells: 27

The 27 transactions

Date	Who	Role	Transaction	Shares	Price	Amount
2026-10-14	Murphy Andrew J	Co-Chief Scientific Officer	sell	463	780,63	$361,432
2026-10-14	Murphy Andrew J	Co-Chief Scientific Officer	sell	454	778,64	$353,503
2026-10-14	Murphy Andrew J	Co-Chief Scientific Officer	sell	380	779,59	$296,244
2026-10-14	Murphy Andrew J	Co-Chief Scientific Officer	sell	376	775,46	$291,573
2026-10-14	Murphy Andrew J	Co-Chief Scientific Officer	sell	283	771,56	$218,351
2026-10-14	Murphy Andrew J	Co-Chief Scientific Officer	sell	279	766,47	$213,845
2026-10-14	Murphy Andrew J	Co-Chief Scientific Officer	sell	271	765,39	$207,421
2026-10-14	Murphy Andrew J	Co-Chief Scientific Officer	sell	224	773,40	$173,242
2026-10-14	Murphy Andrew J	Co-Chief Scientific Officer	sell	219	764,40	$167,404
2026-10-14	Murphy Andrew J	Co-Chief Scientific Officer	sell	211	772,56	$163,010
2026-10-14	Murphy Andrew J	Co-Chief Scientific Officer	sell	192	767,39	$147,339
2026-10-14	Murphy Andrew J	Co-Chief Scientific Officer	sell	127	769,30	$97,701
2026-10-14	Murphy Andrew J	Co-Chief Scientific Officer	sell	121	774,48	$93,712
2026-10-14	Murphy Andrew J	Co-Chief Scientific Officer	sell	105	768,33	$80,675
2026-10-14	Murphy Andrew J	Co-Chief Scientific Officer	sell	74	760,65	$56,288
2026-10-14	Murphy Andrew J	Co-Chief Scientific Officer	sell	66	776,31	$51,236
2026-10-14	Murphy Andrew J	Co-Chief Scientific Officer	sell	55	762,57	$41,941
2026-10-14	Murphy Andrew J	Co-Chief Scientific Officer	sell	50	781,47	$39,074
2026-10-14	Murphy Andrew J	Co-Chief Scientific Officer	sell	38	777,76	$29,555
2026-10-14	Murphy Andrew J	Co-Chief Scientific Officer	sell	35	755,91	$26,457
2026-10-14	Murphy Andrew J	Co-Chief Scientific Officer	sell	27	761,36	$20,557
2026-10-14	Murphy Andrew J	Co-Chief Scientific Officer	sell	25	763,76	$19,094
2026-10-14	Murphy Andrew J	Co-Chief Scientific Officer	sell	24	758,16	$18,196
2026-10-14	Murphy Andrew J	Co-Chief Scientific Officer	sell	16	757,68	$12,123
2026-10-14	Murphy Andrew J	Co-Chief Scientific Officer	sell	14	759,96	$10,639
2026-10-14	Murphy Andrew J	Co-Chief Scientific Officer	sell	12	770,20	$9,242
2026-10-14	Murphy Andrew J	Co-Chief Scientific Officer	sell	6	753,76	$4,523

How to read these transactions

There are 27 filed transactions for REGENERON PHARMACEUTICALS, INC. (REGN) between 2026-10-14 and 2026-10-14. All of them are by the same person. Open-market buys: 0, for $0. Sells: 27, for $3,204,376.

Each transaction comes from a Form 4, the filing the person submits to the SEC. In the table, each row is one transaction: the date, who made it and their role, whether it is a buy or a sell, the number of shares, the declared price per share and the total amount.

Open-market buys are the ones people watch most, because whoever makes them puts in their own money. Sells say less: they often respond to taxes, diversification or sale plans scheduled in advance. A single transaction does not say much either; what people look at is whether they repeat, from how many people and for what amount.

Other companies with insider trades

RICHARDSON ELECTRONICS, LTD. (RELL) · Remitly Global, Inc. (RELY) · Rent the Runway, Inc. (RENT) · REX AMERICAN RESOURCES Corp (REX) · RGC RESOURCES INC (RGCO) · REPLIGEN CORP (RGEN) · ROYAL GOLD INC (RGLD) · STURM RUGER & CO INC (RGR)

Also on Arvenyx

US Congress members who disclosed trades in it: Gilbert Cisneros · Julia Letlow

Public SEC data (EDGAR), Form 4. Open-market buys and sells only: option exercises and stock received as pay are left out. This is not investment advice.

Follow them next to your own portfolio

In Arvenyx you see these portfolios, insider buys and your own portfolio, across all your brokers, in one place.

Create a free account